Overview


According to FutureWise analysis the market for acellular dermal matrices in 2023 is US$ 8.84 billion, and is expected to reach US$ 22.40 billion by 2031 at a CAGR of 12.32%.

Acellular dermal matrices are medical implants used in reconstructive and plastic surgery procedures. These substances are derived from either human or animal tissue and undergo a meticulous process to remove cellular components while preserving the extracellular matrix (ECM). The ECM is the complex network of proteins and other molecules that provide structural support and signaling cues to cells. ADMs serve as scaffolds or templates for tissue regeneration. When implanted into the body, they provide a framework for host cells to migrate, proliferate, and remodel, ultimately promoting tissue regeneration. The primary purpose of ADMs is to restore or enhance damaged or deficient soft tissue, such as skin, subcutaneous fat, or muscle.

During the processing of ADMs, cellular and genetic components are removed, mitigating the potential for disease transmission. The resultant acellular matrix preserves its original structure and biochemical characteristics, encompassing growth factors, cytokines, and other signaling molecules that possess the ability to foster tissue healing and regeneration. Surgeons frequently employ ADMs in diverse surgical interventions, including mastectomy-based breast reconstruction, abdominal wall reconstruction, and wound healing. These matrices assist in integrating tissue and promote the development of fresh blood vessels and connective tissue.

FutureWise Market Research has published a report that provides an insightful analysis of Acellular Dermal Matrices Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Acellular Dermal Matrices Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Zimmer Biomet
  • Stryker Corporation
  • Staumann, Allergan, Inc.
  • Conmed
  • Integra LifeSciences Corporation
  • Aziyo Biologics
  • Hospital Innovations
  • Medtronic, Inc.
  • Synthes, Inc.
  • Gunze Corp.
  • Cook Medical Incorporated
  • C. R. Bard, Inc.
  • HANS BIOMED CORP.

(Note: The list of the major players will be updated with the latest market scenario and trends)

The global acellular dermal matrices market has experienced significant expansion in the recent years, driven by various factors such as technological advancements, increasing prevalence of chronic wounds, and a growing demand for regenerative medicine solutions. One of the key drivers in the ADM market is the continuous development of advanced technologies. Researchers and manufacturers are constantly trying to improve the efficacy and safety of ADMs by introducing innovative manufacturing techniques, such as decellularization methods, to remove cellular or genetic components and retain the structural integrity and bioactivity of the matrix. These advancements have led to the availability of high-quality ADMs with enhanced regenerative properties, which has positively impacted market growth. The prevalence of chronic wounds, including diabetic foot ulcers, pressure ulcers, and venous leg ulcers, is on the rise and it act as a significant driver for the market. These conditions pose a significant healthcare burden worldwide and require advanced wound care solutions for effective healing. As a result, the rising incidence of chronic wounds has fueled the demand for ADMs, contributing to market growth.

However, ADM market faces challenges including high costs, regulatory complexities, reimbursement issues, and ethical considerations. The complex manufacturing processes, stringent quality control requirements, and extensive studies contribute to the high cost of ADMs, limiting their adoption in resource-limited settings. Hence, these restraining factors must be addressed for the sustainable growth of the target market.

By Material Type

  • Polyhydroxyalkanoate (PHA)
  • Silicone
  • Dispersants

By Tissue Origin

  • Human
  • Porcine
  • Bovine

By Application

  • Orthopedics
  • Plastic Surgery
  • General Surgery
  • Repair and Replacement of Tissue (Wound Coverage)
  • Dental
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. The increasing occurrence of breast cancer in North America is projected to establish the region as a key player in the global acellular dermal matrices market. Statistics provided by the Breast Cancer Organization indicate that approximately 1 in 8 women in the U.S. will develop invasive breast cancer in their lifetime. This escalating prevalence of breast cancer among the population will consequently lead to a higher number of mastectomy cases. Consequently, the demand for acellular dermal matrices is expected to grow, driving market expansion during the forecast period.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Acellular Dermal Matrices Market By Material Type, By Tissue Origin, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Acellular Dermal Matrices Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Acellular Dermal Matrices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Acellular Dermal Matrices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Acellular Dermal Matrices Market, By Material Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Polyhydroxyalkanoate (PHA)
        2. Silicone
        3. Dispersants

  • 8.   Acellular Dermal Matrices Market, By Tissue Origin Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Human
        2. Porcine
        3. Bovine

  • 9.   Acellular Dermal Matrices Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Orthopedics
        2. Plastic Surgery
        3. General Surgery
        4. Repair and Replacement of Tissue (Wound Coverage)
        5. Dental
        6. Others

  • 10.   North America Acellular Dermal Matrices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Acellular Dermal Matrices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Acellular Dermal Matrices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Acellular Dermal Matrices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Zimmer Biomet
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Stryker Corporation
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Staumann, Allergan, Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Conmed
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Integra LifeSciences Corporation
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Aziyo Biologics
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Hospital Innovations
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Medtronic, Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Synthes, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Gunze Corp.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Cook Medical Incorporated
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12.C. R. Bard, Inc.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. HANS BIOMED CORP.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

Related Market

Extracellular Matrix Proteins Market

Read More

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11